Autoantibodies against galectin-8: Their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation

Lupus

Volumn 18, Issue 6, 2009, Pages 539-546

  Massardo, L ^a   Metz, C ^a,b,c   Pardo, E ^b,c   Mezzano, V ^a   Babul, M ^b   Jarpa, E ^a   Guzman A M ^b   Andre S ^d   Kaltner, H ^d   Gabius, H J ^d   Jacobelli, S ^a   Gonzalez A ^a,c,d   Soza, Andrea ^a,c,d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSIDAD ANDRÉS BELLO   (Chile)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autoantibodies; Galectin 8; Lymphopenia; SLE

Indexed keywords

AUTOANTIBODY; GALECTIN; GALECTIN 8; PREDNISONE; PROTEIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; SEPTICEMIA; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIGENS, NEOPLASM; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BLOTTING, WESTERN; CHILD; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FOLLOW-UP STUDIES; GALECTINS; GENE EXPRESSION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOPENIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 65549122918     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308099973     Document Type: Article

References (65)

1. Dubois Lupus Erythematosus. Philadelphia, USA: Lippincott Williams and Wilikins; 2007.
2. Rahman A Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008; 358: 929-939.
3. Sawalha AH Harley JB. Antinuclear autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 2004; 16: 534-540.
4. Rabinovich GA Liu FT Hirashima M Anderson A. An emerging role for galectins in tuning the immune response: Lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol 2007; 66: 143-158.
5. Gabius HJ. Animal lectins. Eur J Biochem 1997; 243: 543-576.
6. Brewer FC. Binding and cross-linking properties of galectins. Biochim Biophys Acta 2002; 1572: 255-262.
7. Zick Y Eisenstein M Goren RA Hadari YR Levy Y Ronen D. Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj J 2004; 19: 517-526.
8. Wang JL; Gray RM; Haudek KC; Patterson RJ; Nucleocytoplasmic lectins. Biochim Biophys Acta 2004; 1673: 75-93.
9. Andre S Sanchez-Ruderisch H Nakagawa H. Tumor suppressor p16INK4a-modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J 2007; 274: 3233-3256.
10. Gabius HJ. The sugar code. Fundamentals of glycosciences. Weinheim, Germany: Wiley-VCH; 2008.
11. Carlsson S Oberg CT Carlsson MC. Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology 2007; 17: 663-676.
12. Hadari YR Paz K Dekel R Mestrovic T Accili D Zick Y. Galectin-8. A new rat lectin, related to galectin-4. J Biol Chem 1995; 270: 3447-3453.
13. Bidon N Brichory F Bourguet P Le Pennec JP Dazord L. (Review) Galectin-8: A complex sub-family of galectins. Int J Mol Med 2001; 8: 245-250.
14. Tribulatti MV Mucci J Cattaneo V. Galectin-8 induces apoptosis in the CD4(high)CD8(high) thymocyte subpopulation. Glycobiology 2007; 17: 1404-1412.
15. Danguy A Rorive S Decaestecker C. Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histol Histopathol 2001; 16: 861-868.
16. Lahm H Andre S Hoeflich A. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 2001; 127: 375-386.
17. Langbein S Brade J Badawi JK. Gene-expression signature of adhesion/ growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 2007; 51: 681-690.
18. Nagy N Bronckart Y Camby I. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut 2002; 50: 392-401.
19. Nishi N Shoji H Seki M. Galectin-8 modulates neutrophil function via interaction with integrin alphaM. Glycobiology 2003; 13: 755-763.
20. Eshkar Sebban L Ronen D Levartovsky D. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J Immunol 2007; 179: 1225-1235.
21. Pardo E Carcomo C Massardo L. Antibodies against galectin-8 in patients with systemic lupus erythematosus Rev Med Chil 2006; 134: 159-166.
22. Carcomo C Pardo E Oyanadel C. Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells. Exp Cell Res 2006; 312: 374-386.
23. Gabius HJ. Influence of type of linkage and spacer on the interaction of beta-galactoside-binding proteins with immobilized affinity ligands. Anal Biochem 1990; 189: 91-94.
24. Andre S Kaltner H Furuike T Nishimura S Gabius HJ. Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets. Bioconjug Chem 2004; 15: 87-98.
25. Beer A Andre S Kaltner H. Human galectins as sensors for apoptosis/ necrosis-associated surface changes of granulocytes and lymphocytes. Cytometry A 2008; 73: 139-147.
26. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
27. Gladman DD Ibanez D Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288-291.
28. Gladman DD Goldsmith CH Urowitz MB. The Systemic Lupus International Collaborating Clinics/American College of rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000; 27: 373-376.
29. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
30. Diagnostic and statistical manual of mental disorders Washington; 2004.
31. Arnett FC Edworthy SM Bloch DA. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
32. Prevoo ML van 't Hof MA Kuper HH van Leeuwen MA van de Putte LB van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-48.
33. Yu HH Wang LC Lee JH Lee CC Yang YH Chiang BL. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients. Rheumatology (Oxford) 2007; 46: 1492-1494.
34. Lutomski D Joubert-Caron R Lefebure C. Anti-galectin-1 autoantibodies in serum of patients with neurological diseases. Clin Chim Acta 1997; 262: 131-138.
35. Romero MD Muino JC Bianco GA. Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis. Invest Ophthalmol Vis Sci 2006; 47: 1550-1556.
36. Giordanengo L Gea S Barbieri G Rabinovich GA. Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: Differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease. Clin Exp Immunol 2001; 124: 266-273.
37. Jensen-Jarolim E Neumann C Oberhuber G. Anti-Galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries. J Clin Immunol 2001; 21: 348-356.
38. Lim Y Lee DY Lee S. Identification of autoantibodies associated with systemic lupus erythematosus. Biochem Biophys Res Commun 2002; 295: 119-124.
39. Scanlan MJ Chen YT Williamson B. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998; 76: 652-658.
40. Rivero SJ Diaz-Jouanen E Alarcon-Segovia D. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum 1978; 21: 295-305.
41. Grigor R Edmonds J Lewkonia R Bresnihan B Hughes GR. Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis 1978; 37: 121-128.
42. Vila LM Alarcon GS McGwin G Bastian HM Fessler BJ Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 2006; 55: 799-806.
43. Wenzel J Gerdsen R Uerlich M Bauer R Tueting T Bieber T. Lymphocytopenia in lupus erythematosus: Close in vivo association to autoantibodies targeting nuclear antigens. Br J Dermatol 2004; 150: 994-998.
44. Ibid
45. Lenert P Lenert G Senecal JL. CD4-reactive antibodies in systemic lupus erythematosus. Hum Immunol 1996; 49: 38-48.
46. Silvestris F Grinello D Tucci M Cafforio P Dammacco F. Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus. Lupus 2003; 12: 8-14.
47. Shoenfeld Y Zamir R Joshua H Lavie G Pinkhas J. Human monoclonal anti-DNA antibodies react as lymphocytotoxic antibodies. Eur J Immunol 1985; 15: 1024-1028.
48. Stafford HA Chen AE Anderson CJ. Anti-ribosomal and P-peptide'-specific autoantibodies bind to T lymphocytes. Clin Exp Immunol 1997; 109: 12-19.
49. Silva LM Garcia AB Donadi EA. Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations. J Neurol 2002; 249: 1048-1054.
50. Sherer Y Gorstein A Fritzler MJ Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004; 34: 501-537.
51. Bonfa E Golombek SJ Kaufman LD. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317: 265-271.
52. Reichlin M. Ribosomal P antibodies and CNS lupus. Lupus 2003; 12: 916-918.
53. Sun KH Tang SJ Lin ML Wang YS Sun GH Liu WT. Monoclonal antibodies against human ribosomal P proteins penetrate into living cells and cause apoptosis of Jurkat T cells in culture. Rheumatology (Oxford) 2001; 40: 750-756.
54. Toubi E Shoenfeld Y. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 2007; 6: 119-125.
55. Massardo L Burgos P Martinez ME. Antiribosomal P protein antibodies in Chilean SLE patients: No association with renal disease. Lupus 2002; 11: 379-383.
56. Ruiz-Arguelles A Rivadeneyra-Espinoza L Alarcon-Segovia D. Antibody penetration into living cells: Pathogenic, preventive and immuno-therapeutic implications. Curr Pharm Des 2003; 9: 1881-1887.
57. Koscec M Koren E Wolfson-Reichlin M. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J Immunol 1997; 159: 2033-2041.
58. Reichlin M. Cellular dysfunction induced by penetration of autoantibodies into living cells: Cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins. J Autoimmun 1998; 11: 557-561.
59. Matus S Burgos PV Bravo-Zehnder M. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med 2007; 204: 3221-3234.
60. Hughes RC. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1999; 1473: 172-185.
61. Hadari YR Arbel-Goren R Levy Y. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 2000; 113: 2385-2397.
62. Levy Y Arbel-Goren R Hadari YR. Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem 2001; 276: 31285-31295.
63. Blank M Waisman A Mozes E Koike T Shoenfeld Y. Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome. Int Immunol 1999; 11: 1917-1926.
64. Marai I Tincani A Balestrieri G Shoenfeld Y. Anticardiolipin and anti-beta-2-glycoprotein I antibodies. Autoimmunity 2005; 38: 33-38.
65. Sebban EL Ronen D Levartovsky D. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J Immunol 2007; 179: 1225-1235.